In new study completed in Switzerland and the UK, researchers identified a specific strain of bacteria as a potential trigger for the early stages of Rheumatoid Arthritis.
read moreAlthough the concept of beneficial bacteria is no longer novel, in recent decades there has been increasing attention paid to the potential effects of probiotics. Generally, existing research supports that probiotics have rather limited benefits that extend only to specific conditions. While probiotics may be limited, microbial therapeutics including Intestinal Microbiota Transplants (IMT) are increasingly being used to treat specific diseases and conditions.
read moreFor the U of M's Microbiota Therapeutics Program team, this work is personal. Amanda Kabage's life saving Intestinal Microbiota Transplant not only gave her health back, but a new career focus.
read moreExposure to air pollution alters gut microbiome composition, subsequently increases the risk of obesity, diabetes, and other chronic illnesses.
read moreA study in mice suggests that by infiltrating tumors and ramping up the body’s immune response, a type of gut bacteria could be a valuable ally in cancer treatment.
read moreThe study, a collaborative work conducted by researchers from Deakin University, Barwon Health and the Murdoch Children’s Research Institute (MCRI) – is the first to show that children with a lower amount of Prevotella at age one are more likely to have anxiety-like behaviours at two, supporting what Harvard researchers have termed “the gut-brain connection”.
read moreResearchers have identified a distinct collection of bacteria found in the gut that may contribute to, and predict, the development of pulmonary arterial hypertension (PAH).
read moreA long term study investigating the impact of microbiota therapy on Autism Spectrum Disorder symptoms was completed at the Arizona State University. The treatment protocol included antibiotics, a bowel cleanse, and a high dose of Intestinal Microbiota Transfer. Prior to treatment, 83% of the children were classified as “severe” on the autism spectrum. At the two-year post-treatment follow up, only 17% classified as severe and 44% of the children fell below the Autism Spectrum Disorder diagnostic cut-off point.
read moreAchieving Cures Together is honored to be highlighted with Dr. Khoruts and the University of Minnesota's Microbiota Therapeutics Program for our development of encapsulated microbiota.
read moreA study of early school-aged children shows a connection between the bacteria in their gut and their behavior, and that parents play a key role in their kids’ microbiome beyond the food they provide. The analysis showed that children with behavioral problems and higher socioeconomic stress had different microbiome profiles than those who didn’t, and also that the quality of the parent-child relationship, as well as parental stress, played a role in how pronounced those differences were.
read more
